2nd International Symposium on Biology, Prevention, and Treatment of Toxicities After Transplantation and Cellular Therapy
2nd International Symposium on Biology, Prevention, and Treatment of Toxicities After Transplantation and Cellular Therapy is organized by Memorial Sloan Kettering Cancer Center (MSKCC) and will be held from Oct 11 - 12, 2019 at Mortimer B. Zuckerman Research Center, New York City, New York, United States of America. This CME conference has been approved for a maximum of 14.50 AMA PRA Category 1 Credits™.
Today, more than 10,000 hematopoietic cell transplantations (HCTs) are performed yearly in the United States as treatment for more than 70 life threatening illnesses including cancers, genetic disorders, and other diseases. Also, given the shift toward cellular therapies in the field of HCT, the number of patients treated with these novel biologic agents is rapidly increasing.
Following the successful examples of the international symposia focusing on GVHD and relapse after HCT, this symposium will bring together experts and thought leaders from around the world in the fields of HCT, cellular therapies, and related medical subspecialties. Speakers will discuss mechanisms of toxicities and symptom burden after HCT and cellular therapies, current advances in the field, and best practices to both prevent and treat these toxicities and symptoms.
The target audience for this symposium includes physicians, researchers, fellows, advanced practice providers, nurses, and pharmacists who provide care for patients undergoing HCT and cellular therapies.
Call for Abstracts:
The 2nd International Symposium on Biology, Prevention, and Treatment of Toxicities After Transplantation and Cellular Therapy invites the submission of abstracts. Abstracts for the poster session will be selected on the basis of scientific merit and content quality. Abstract submission is open to all, and we also highly encourage fellows, residents, pharmacists, and advanced practice providers to submit relevant abstracts in the area of biology, prevention, and treatment of toxicities after transplantation and cellular therapy. In addition, abstracts related to trials and/or clinical research in progress will be accepted. Top awarded abstracts will receive a travel grant tied to attending this symposium.
To submit an abstract, please select the 'Abstract' button above. Submission deadline: Thursday, August 31, 2019.
Networking Reception & Poster Abstract Session
Course attendees are invited to join the faculty for a networking reception and poster abstract session immediately following the completion of day one, Friday, October 11, from 6:15-7:30 pm in the lobby of Zuckerman Research center. Hors d’oeuvres and refreshments will be served. Please RSVP during course registration.
• Understand the mechanisms of the most common treatment-related toxicities after HCT and cellular therapy.
• Identify best practices to prevent and treat toxicities and symptom burden after HCT and cellular therapy to improve the patient experience and reduce non-relapse mortality.
• Understand how to approach prevention and treatment of toxicities and symptom burden in unique HCT and cellular therapy patient populations.
|Contact No. :||646-227-2025
August 31, 2019
|Registration Type||End Date||Price|
|Physicians (MDs, PhDs, PharmDs and DOs) - Early Fee||31 Aug,2019||USD 350.00|
|Physicians (MDs, PhDs, PharmDs and DOs) - Regular Fee||10 Oct,2019||USD 400.00|
|Advanced Practice Providers, Nurses, and Other Healthcare Providers - Early Fee||31 Aug,2019||USD 200.00|
|Advanced Practice Providers, Nurses, and Other Healthcare Providers - Regular Fee||10 Oct,2019||USD 250.00|
|Residents, Fellows - Early Fee||31 Aug,2019||USD 150.00|
|Residents, Fellows - Regular Fee||10 Oct,2019||USD 200.00|
|Industry Professionals - Early Fee||31 Aug,2019||USD 650.00|
|Industry Professionals - Regular Fee||10 Oct,2019||USD 700.00|